Safety and Efficacy of Folfox4 + Weekly Cetuximab vs Folfox 4+Biweekly Cetuximab by Metastatic Colorectal Cancer (CORE 2)

This study is ongoing, but not recruiting participants.

Sponsor:

Information provided by (Responsible Party):

Central European Cooperative Oncology Group

ClinicalTrials.gov Identifier:

NCT00479752

First received: May 25, 2007

Last updated: December 11, 2012

Last verified: December 2012

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	November 2013
Primary Completion Date:	June 2010 (Final data collection date for primary outcome measure)